Skip to main content
Journal cover image

Con: Methylprednisolone is not indicated for patients during cardiopulmonary bypass.

Publication ,  Journal Article
Sulzer, CF; Mackensen, GB; Grocott, HP
Published in: J Cardiothorac Vasc Anesth
April 2005

Duke Scholars

Published In

J Cardiothorac Vasc Anesth

DOI

ISSN

1053-0770

Publication Date

April 2005

Volume

19

Issue

2

Start / End Page

255 / 258

Location

United States

Related Subject Headings

  • Postoperative Complications
  • Neuroprotective Agents
  • Methylprednisolone
  • Lung Diseases
  • Inflammation
  • Humans
  • Clinical Trials as Topic
  • Cardiopulmonary Bypass
  • Anti-Inflammatory Agents
  • Anesthesiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sulzer, C. F., Mackensen, G. B., & Grocott, H. P. (2005). Con: Methylprednisolone is not indicated for patients during cardiopulmonary bypass. J Cardiothorac Vasc Anesth, 19(2), 255–258. https://doi.org/10.1053/j.jvca.2005.02.008
Sulzer, Christopher F., G Burkhard Mackensen, and Hilary P. Grocott. “Con: Methylprednisolone is not indicated for patients during cardiopulmonary bypass.J Cardiothorac Vasc Anesth 19, no. 2 (April 2005): 255–58. https://doi.org/10.1053/j.jvca.2005.02.008.
Sulzer CF, Mackensen GB, Grocott HP. Con: Methylprednisolone is not indicated for patients during cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2005 Apr;19(2):255–8.
Sulzer, Christopher F., et al. “Con: Methylprednisolone is not indicated for patients during cardiopulmonary bypass.J Cardiothorac Vasc Anesth, vol. 19, no. 2, Apr. 2005, pp. 255–58. Pubmed, doi:10.1053/j.jvca.2005.02.008.
Sulzer CF, Mackensen GB, Grocott HP. Con: Methylprednisolone is not indicated for patients during cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2005 Apr;19(2):255–258.
Journal cover image

Published In

J Cardiothorac Vasc Anesth

DOI

ISSN

1053-0770

Publication Date

April 2005

Volume

19

Issue

2

Start / End Page

255 / 258

Location

United States

Related Subject Headings

  • Postoperative Complications
  • Neuroprotective Agents
  • Methylprednisolone
  • Lung Diseases
  • Inflammation
  • Humans
  • Clinical Trials as Topic
  • Cardiopulmonary Bypass
  • Anti-Inflammatory Agents
  • Anesthesiology